Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results

February 11, 2026 - 18:45

SAN JOSE, Feb. 11, 2026 -- Outset Medical, a company focused on innovative dialysis technology, has released its financial results for the final quarter and the full year concluding on December 31, 2025. The company reported a period of revenue growth and strategic advancement.

For the fourth quarter, net revenue reached $28.9 million. This contributed to a full-year 2025 revenue total of $119.5 million, representing a 5% increase compared to the $113.7 million reported for the previous year. This growth underscores the company's ongoing commercial execution in the medical technology sector.

Leadership expressed confidence in the company's trajectory, highlighting the performance as a reflection of their commitment to transforming dialysis care. The focus remains on deploying technology designed to reduce the complexity and cost associated with traditional dialysis treatments while aiming to improve patient outcomes. The reported financials position the company for continued investment in its commercial footprint and product development initiatives as it moves into the new year. The company's vision centers on making dialysis more accessible and efficient for patients and healthcare providers alike.